TITLE

Bowel Habit Subtypes and Temporal Patterns in Irritable Bowel Syndrome: Systematic Review

AUTHOR(S)
Guilera, Magda; Balboa, Agustín; Mearin, Fermín
PUB. DATE
May 2005
SOURCE
American Journal of Gastroenterology;May2005, Vol. 100 Issue 5, p1174
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Irritable bowel syndrome (IBS) is a heterogeneous condition characterized by the presence of abdominal discomfort or pain and bowel habit alterations: constipation (C-IBS), diarrhea (D-IBS), or alternating C and D (A-IBS). Its clinical course is poorly known.OBJECTIVES: (i) To compare bowel habit subtypes distribution in IBS according to sample origin and diagnosis criteria; (ii) To evaluate IBS temporal patterns based on follow-up studies.METHODS: A literature search (1966–2003) was conducted in the MEDLINE and EMBASE databases. A total of 72 studies were found and 22 were finally selected.RESULTS: Population-based studies from the United States (Manning) found similar distribution among C-IBS, D-IBS, and A-IBS, while European studies (Rome I, Rome II, or self-reporting) showed either C-IBS or A-IBS as the most prevalent subtypes. Primary care office-based studies (Rome I or Rome II) showed A-IBS as the most prevalent group. Gastroenterology specialized office-based studies found either C-IBS or D-IBS as the most frequently reported subtype. Prospective follow-up investigations showed that the most frequent IBS temporal pattern profile consists of mild to moderate symptoms appearing in cluster in an intermittent way, about once a week, and lasting 2–5 days on average.CONCLUSION: IBS clinical subtypes distribution differs depending on the population evaluated, the geographical location, and the criteria employed to define IBS and bowel habit subtypes. In most cases, clinical course is characterized by the presence of mild-to-moderate symptoms appearing sequentially. Prospective studies, using clear and stable diagnostic criteria and subtype definitions, and based on daily data collection should further characterize IBS clinical course.(Am J Gastroenterol 2005;100:1174–1184)
ACCESSION #
16783599

 

Related Articles

  • The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Rogha, Mehran; Esfahani, Mozhdehalsadat Zahiri; Zargarzadeh, Amir Houshang // Gastroenterology & Hepatology from Bed to Bench;Summer2014, Vol. 7 Issue 3, p156 

    Aim: We aimed to evaluate the efficacy of a synbiotic containing Bacillus Coagulans in treatment of IBS. Background: Some studies have shown the efficacy of probiotics in the treatment of irritable bowel syndrome (IBS). Patients and methods: Adult IBS patients (n=85) were randomized to receive a...

  • A cost analysis of functional bowel disorders in Iran. Roshandel, Delnaz; Rezailashkajani, Mohammadreza; Shafaee, Sepideh; Zali, Mohammad // International Journal of Colorectal Disease;Jul2007, Vol. 22 Issue 7, p791 

    The objective of this work is to evaluate the health care utilization and cost of different types of functional bowel disorder (FBD) in a population of Iranian patients and compare the costs in consulters and non-consulters. A consecutive sample of 1,023 patients in an outpatient...

  • Randomized Clinical Trial: The Clinical Effects of Herb-Partitioned Moxibustion in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome. Yu-xia Ma; Xiao Liu; Cun-zhi Liu; Lin-peng Wang; Gang Guo; Dong-qing Du; Zhi-lei Wang; Hong Ma; Ping Qi; Zhao-feng Li; Yan-ping Guo; Hua-qiang Yi; Shu-zhong Gao // Evidence-based Complementary & Alternative Medicine (eCAM);2013, Vol. 2013, p1 

    Objective. To explore the efficacy of Herb-partitioned moxibustion in treating IBS-D patients. Method. 210 IBS-D patients were randomly assigned on a 3 : 3 : 2 basis to group HM, group FM, or group PB for 4-week treatment. The change of GSRS total score at weeks 4 and 8, the changes of GSRS...

  • Pathogenesis of Irritable Bowel Syndrome: Is It Really in the Gene? Ghoshal, Uday C.; Singh, Rajan // Journal of Neurogastroenterology & Motility;Jul2014, Vol. 20 Issue 3, p284 

    The author reflects on the role of genetic factors in occurrence of irritable bowel syndrome (IBM). He makes reference to a study published in the journal which evaluates association between IBM and serotonin transporter (SLC6A4) polymorphism. The study reveals that patients with constipation...

  • Meal induced rectosigmoid tone modification: a low caloric meal accurately separates functional and organic gastrointestinal disease patients. di Stefano, M.; Miceli, E.; Missanelli, A.; Mazzocchi, S.; Corazza, G. R. // Gut;Oct2006, Vol. 55 Issue 10, p1409 

    Background and aims: Diagnosis of irritable bowel syndrome (IBS) is based on arbitrary criteria due to the lack of an accurate diagnostic test. The aim of this study was to evaluate whether rectosigmoid tone modification after a meal represents an accurate diagnostic approach. Methods: In a...

  • Tegaserod for Female Patients Suffering From IBS With Mixed Bowel Habits or Constipation: A Randomized Controlled Trial. Chey, William D.; Paré, Pierre; Viegas, Andrea; Ligozio, Gregory; Shetzline, Michael A. // American Journal of Gastroenterology;May2008, Vol. 103 Issue 5, p1217 

    OBJECTIVES: Though the greatest proportion of irritable bowel syndrome (IBS) patients report a mixed bowel pattern (IBS-Mixed), no available therapies have been rigorously evaluated in this subgroup. This study aimed to evaluate the efficacy and safety of the 5-HT4 agonist tegaserod in women...

  • Long-Term Outcome of Rifaximin Therapy in Non-constipation Irritable Bowel Syndrome. Weinstock, Leonard // Digestive Diseases & Sciences;Nov2011, Vol. 56 Issue 11, p3389 

    No abstract available.

  • Tips for Promoting Good Digestive Health.  // IDEA Fitness Journal;Nov/Dec2008, Vol. 5 Issue 10, p96 

    The article offers tips for promoting good digestive health and prevent common digestive ailments. It suggests consuming 20-35 grams per day of fiber to prevent constipation, diarrhea and symptoms of irritable bowel syndrome. It emphasizes the significance of making good food choices and...

  • Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran. Roshandel, Delnaz; Rezailashkajani, Mohammadreza; Shafaee, Sepideh; Zali, Mohammad Reza // International Journal of Colorectal Disease;Dec2006, Vol. 21 Issue 8, p814 

    There are scanty data on functional bowel disorder (FBD) patterns in Iran. This first-time study tried to provide preliminary data on relative distribution of different types of FBD and their symptom patterns in Iranian patients. A consecutive sample of 1,023 patients in an outpatient...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics